As HPV is infectious, there is potential for protection of unvaccinated individuals and herd immunity is a prospect with HPV. Various papers have been published modelling the impact that HPV vaccination could have at a population level.(3-8) Newall et al critiqued papers published on the impact of HPV vaccination and emphasised the importance of measuring the effect of herd immunity.(6) The impact of herd immunity was modelled by demonstrating the effects of vaccinating different percentages of females only or females and males.(5,7) Taira et al demonstrated that the effects of herd immunity could considerably influence lifetime cervical cancer incidence.(8) These results are explained by Garnett, who states that herd immunity, and hence vaccine effectiveness, can be influenced by whether both males and females are vaccinated; the percentage of individuals vaccinated; at what point in one’s sexual life they are vaccinated; the availability of screening for cervical cancer in the population; and distributions of infection.(3) While the model of herd immunity for HPV is a complicated one, it does exist.As I said, I can't find any medical reports that say HPV won't be effected by "herd immunity".3. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005; 191 Suppl 1:S97-106.
4. Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology 2002; 13:631-9.
5. Kulasingam S, Connelly L, Conway E, et al. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. Sex Health 2007; 4:165-75.
6. Newall AT, Beutels P, Wood JG, Edmunds WJ, MacIntyre CR. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis 2007; 7:289-96.
7. Regan DG, Philp DJ, Hocking JS, Law MG. Modelling the population-level impact of vaccination on the transmission of human
papillomavirus type 16 in Australia. Sex Health 2007; 4:147-63.
8. Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination programs. Emerg Infect Dis 2004; 10:1915-23.
I didn’t say that. What I did say is that if you were to inoculate 80 percent of the population, you will not get the same effect of herd immunity as you do with DPT or MMR. Which your study confirms.
Inoculations have a threshold. This is why it’s these six, Diptheria, Pertussis, Tetanus, Measles, Mumps and Rubella all exhibit this characteristic. HPV does not reach the same threshold as the others. So even under ideal conditions, the shot isn’t an effective vaccine.
“cost of 382 one-time deaths from the vaccine”
You can die more than once?
Umm, Charles, these aren’t ‘one-time’ deaths. These are deaths that will continue, because you can’t just stop vaccinating people.
Papilloma viruses have disease vectors in animals too. This isn’t like smallpox.